Introduction
Posterior peridural fibroblastic invasion after spinal surgery has been recognized as the basic cause of "laminectomy membrane" [4, 17] , a dense fibrous tissue that replaces bone removed at laminectomy and can bind the dura to overlying muscles [2] . Laminectomy membrane appears in most patients who have undergone procedures involving exposure of neural elements [31] . In some patients, it may be responsible for recurrent pain after spinal surgery that necessitates a second operation [6, 8, 9, 30, 32] . Moreover, the presence of peridural fibrosis can increase the difficulty and risks involved in re-exposure during subsequent spinal procedures [18] .
Several different materials and agents have been used experimentally and clinically in attempts to minimize peridural fibrosis, including autologous fat grafts [9, 20] , Abstract Peridural fibrosis developing after laminectomy may cause pain that can necessitate reoperation. Many materials have been used as a barrier to invasion of fibrous tissue into the vertebral canal, but the ideal material has not been found. Various studies in animals have achieved favourable results with an expanded polytetrafluoroethylene (ePTFE) membrane. In a prospective, randomized study, we compared postoperative results in 33 patients who had an ePTFE membrane implanted to cover the defect caused by laminectomy during lumbar spine decompression with the results in 33 patients in whom no material was implanted. At operation, an ePTFE membrane was placed after the decompression procedure to cover the laminectomy defect completely. Systematic clinical and MRI follow-up evaluations of patients with and without the membrane were conducted 3, 6, 12, and 24 months postoperatively. The effect of ePTFE membrane implantation over laminectomy sites on postoperative peridural fibrosis, pain and neurological claudication was assessed. The ePTFE-membrane group had a significantly lower rate of epidural fibrosis on MRI (P < 0.0001) and of clinical manifestations of radiculalgia (P = 0.002) compared with the no-material group. Epidural fibrosis that occurred in the ePTFE group was generally less extensive than that in the no-material group. There was no significant difference in the rate of postoperative claudication in the two groups. Significantly more seromas occurred in the ePTFE group (P = 0.0002). There were no infections or other complications in either group. The results showed that placement of an ePTFE spinal membrane over the laminectomy defect produced by lumbar spine surgery provided a physical barrier to invasion of fibrous tissue into the vertebral canal, and patients with the membrane had less postoperative radicular pain.
Silastic (Dow Corning, Midland, Mich.) [18] , Surgicel (Johnson & Johnson, New Brunswick, N.J.) [16] , Gelfoam (Upjohn, Kalamazoo, Mich.) [17] , polyglactin 910 [25] and more recently, polyvinyl alcohol hydrogel membrane [12] , recombinant tissue-plasminogen activator gel [11] , carbohydrate polymer [28] and sodium hyaluronate [30] . In general, the results achieved with these materials have been unsatisfactory, variable or preliminary.
In 1995, DiFazio et al. [8] described a comparative study of free fat grafts, Silastic sheeting, polytetrafluoroethylene (ePTFE) membrane, and no material used for interposition in a canine model of postlaminectomy peridural fibrosis. The peridural scar was significantly less dense in sites in which the ePTFE membrane had been implanted than in the other sites (P = 0.01). We have also conducted a study in dogs in which we found an ePTFE membrane to be an effective physical barrier for preventing postlaminectomy fibrous invasion of the vertebral canal (unpublished data).
In the light of these results, we began to use an ePTFE spinal membrane (Preclude Spinal Membrane, WL Gore & Associates, Flagstaff, Ariz.; thickness, ~0.7 mm; porosity, ~3 µm) in patients undergoing lumbar spine surgery to cover the defect caused by laminectomy and as a physical barrier against entry of fibrous tissue into the vertebral canal. We here describe a prospective clinical study of our experience with this material as compared with no material in 66 patients evaluated postoperatively by clinical examination and MRI using gadolinium.
Materials and methods
All patients who underwent extensive decompression spinal surgery (laminectomy at one or more levels) between October 1994 and October 1995 were considered for the study. Patients were excluded if they had previously undergone lumbar spine surgery or were followed for fewer than 12 months postoperatively. Sixty-six patients were enrolled from the total, 33 of whom had an ePTFE membrane implanted to cover the laminectomy defect and 33 of whom had no barrier material inserted. Characteristics of the patients in the two groups, including their preoperative symptoms, diagnosis and treatment, are shown in Table 1 .
All patients underwent systemic prophylactic antibiotic therapy with cefazolin given intravenously in a dosage of 1 g at 2 h before surgery and 1 g every 6 h postoperatively, to a maximum of three doses. All patients were operated on by the same surgeon (A.L.). At operation in the patients given the ePTFE membrane, after the posterior decompression procedure had been completed, the laminectomy defect was measured and a piece of ePTFE membrane the same length as the defect was cut (Fig. 1) .
After the membrane was sized and assessed to ensure that it covered the laminectomy defect completely, it was fixed with nonabsorbable monofilament ePTFE CV-3 suture (Gore-Tex Suture, WL Gore & Associates) to the capsule of the adjacent facet articulations. In cases in which only a hemilaminectomy was performed, the membrane was placed in a "bow-string" position from the interspinous ligament to the intertransverse area and fixed with two sutures to the interspinous ligament and two to the capsules of the adjacent facet articulations (Fig. 2) . Regardless of the technique used, aspirating drainage tubes were inserted and left in place for 24-36 h.
Postoperatively, all patients participated in a rehabilitation programme that began 24 h after surgery and ended about 6 months later, depending on their progress. After the surgical wound had healed, systematic follow-up examinations were conducted on an outpatient basis at 3, 6, 12, and 24 months postoperatively. All patients reached the 12-month control at least. Patients were assessed clinically (by motor and sensory evaluations) for manifestations of radiculopathy and neurological claudication. The clinical assessment of patients involved the systematic evaluation of sciatic nerve elongation manoeuvres, inferior extremities muscular balance and 4 7 a Eleven procedures in the ePTFE-membrane group and ten in the no-material group included instrumentation osteotendinous reflexes, besides filling in the normal radichial exploration protocol (weight, height, muscular contracture, mobility, Schöber test, analogue visual pain scale, etc). In addition, all patients underwent MRI to detect the presence of peridural fibrosis and fluid collection posterior to the dural sac (posterior seroma) (Figs. 3, 4) . Peridural fibrosis observed on MRI at the 6-month assessment was graded on a three-part scale with respect to its extension into the vertebral canal. These three parts are bounded by three imaginary parallel lines (Fig. 5 ) which are located on the rear side of the roots (line A) in the medial part of the dural sac (line B) and on the rear side of the dural sac (line C). All seromas found were measured (length and thickness) on the MRI film. Pearson chi-square testing was used to compare the results in the groups with and without an ePTFE membrane, with significance assumed at P < 0.05.
Results
The results in the two groups of patients are shown in Table 2 , which is a summary of the longest follow-up. The patients with the ePTFE membrane were significantly less likely to have postoperative peridural fibrosis on MRI than those in whom no material was used (P < 0.001). Most patients (75.7%) in the ePTFE group had no fibrosis, whereas only 9.1% of those in the no-material group had none (Fig.  6 A-C) . In addition, in the patients with fibrosis, the fibroblastic invasion was more extensive in those with no interpositional material than in those with the ePTFE membrane. A significant difference between the treatment groups was also observed with respect to postoperative radiculalgia, which affected only 3 patients in the ePTFE group but 14 in the no-material group (P = 0.002). No significant difference was observed in the rate of postoperative neurological claudication in the two groups.
There were no infections related to the use of the ePTFE material. Seromas were observed in 27 patients (82%) with an ePTFE membrane and in 12 (36.4%) of those with no material; the difference was significant (P = 0.0002). The mean seroma thickness in the ePTFE group was 1.7 mm, whereas that in the no-material group was 1.5 mm. All seromas observed were the same length as the laminectomy defect. In all cases, the size of seromas was not changed after MRI evaluation.
Discussion
Recurrent or persistent pain after lumbar spine surgery affects 5-40% of patients [7] , many of whom will require reoperation. Numerous factors may be involved in failed back surgery, including instability, radicular trapping that prevents the root from following its foraminal route, and inadequate or faulty surgical technique. The association of peridural fibrosis with pain is controversial [1] , but we believe that scarring is involved in some cases of postoperative back pain and that efforts should be made to prevent fibrotic invasion.
The material that has been most commonly used as a barrier to peridural fibrotic invasion in patients undergoing spinal surgery is free and pedicled autologous fat grafts [6, 9, 15, 16] . Fat grafts have been found to decrease dural adhesions or scar density in animal models more effectively than Surgicel [16] , Avitene (Avicon, Fort Worth, Tex.) [16] , collagen [16] , Gelfoam [9, 16, 34] , or polyglactin 910 [25] . Clinically, the results achieved with fat grafts have been variable. Bryant et al. [6] found that autologous fat transplants were well tolerated and may serve as a barrier limiting the growth of scar into the spinal canal. Martin-Ferrer [20] , however, reported a failure of fat grafts to prevent peridural fibrosis. In addition, viable fat grafts shrink over time [6] , the use of fat grafts may cause donor site morbidity, and there have been some reports of an association between fat grafts and serious neurologic complications [21, 26] . Moreover, sufficient quantities of autologous fat are not available in all patients.
Recent experimental research has found local instillation of recombinant tissue-plasminogen activator gel to be ineffective in inhibiting scar formation and adhesion in a canine model of laminectomy [11] . Hyaluronic acid [1] and sodium hyaluronate solution [30] have yielded some promising results in animal studies, but the number of models has been small, and statistical significance in comparisons with fat-graft results has not always been attained. In studies in rabbits, Robertson et al. [28] observed some benefit in using a carbohydrate polymer to prevent peridural fibrosis. Hiraizumi and colleagues [12] were successful in using a polyvinyl alcohol hydrogel membrane as an anti-adhesive interposition material in a feline postlaminectomy model. No clinical experience with any of these agents has been reported. Expanded polytetrafluoroethylene, a biocompatible material, has been used safely and effectively for many years in multiple clinical applications in several surgical areas, including vascular surgery [19, 22, 27] , soft-tissue repair [3] , plastic surgery [23] , gynaecology [5] , cardiac surgery [14] and neurosurgery [13, 33] . In long-term follow-up on patients in whom an ePTFE membrane [3, 10, 27, 33] was implanted, the presence of wear debris was not shown; similarly, the implantation of this membrane in the defect of a rachidial laminectomy is not submitted to the same shear forces that prosthetic articular implants are.
Thin-membrane (small-porosity) forms of ePTFE similar to the ePTFE spinal membrane we used in spinal surgery have functioned as barriers to minimize adhesions in several parts of the body. In a randomized clinical trial, ePTFE membranes reduced postmyomectomy adhesion formation [24] . Jacobs et al. [14] implanted ePTFE membrane pericardial substitutes in 1,085 patients with congenital heart disease to prevent cardiac injury at reoperation. They reoperated on 105 of those patients and found no problematic adhesions between the membrane and the heart or the membrane and the chest wall. Yamagata and colleagues [33] used an ePTFE membrane to repair the dura after craniotomy in 34 patients. In the six patients who underwent reoperation, there were no adhesions between the membrane and brain tissue. Inoue et al. [13] implanted an ePTFE membrane to treat or prevent tethered cord syndrome in 12 patients. During a mean follow-up of 45 months (range, 23 months-7 years) that included MRI evaluations, no adhesions of the spinal cord to the repair site were observed. As mentioned earlier, DiFazio et al. [8] and we (unpublished data) have found that application of an ePTFE membrane at laminectomy in dogs was effective in preventing peridural fibrosis. In this clinical study, about 76% of our patients in whom the ePTFE membrane was used had no peridural fibrosis on MRI. In the patients in whom fibrosis did occur, it was less extensive than that in the patients in whom no material was implanted. We think that the fibrous tissue invasion in the patients with the ePTFE membrane may have occurred in cases in which coverage of the laminectomy defect was not total and the tissue penetrated small areas left in the space between the membrane and the bone limits of the defect. Perhaps a change in the method of anchoring the ePTFE membrane would prevent this partial penetration.
Seromas were observed in most patients in whom the ePTFE membrane was implanted and in some of those in whom no material was used. The seromas may have developed as a result of haematoma contraction during the postoperative period. In general, seroma size did not change during follow-up. The seromas created no clinical problems; none became infected and none required aspiration. There was no relationship between the presence of a seroma and postoperative pain or any other clinical finding in either group of patients.
Additional studies of the relationship between postlaminectomy peridural fibrosis and postoperative pain are needed. An important step would be development of better methods for evaluating the extent and location of fibrosis after spinal surgery. More investigations of barrier materials are also required. However, because of our clinical and experimental results with the ePTFE membrane, we now routinely insert the device in all patients undergoing a decompression operation of the lumbar spine, and believe that its use is a fundamental part of the procedure.
Conclusions
In a clinical series, placement of an ePTFE spinal membrane over the bone defect produced during decompression surgery of the lumbar spine acted as a physical barrier to invasion into the vertebral canal of fibrous tissue produced by scarring of the posterior musculature. Patients in whom the membrane was inserted had a statistically significant reduction in invasion by peridural fibrosis on MRI and in postoperative radiculalgia as compared with patients in whom no material was inserted. Postoperative seromas were more common in the patients with the membrane than in patients with no material, although they produced no clinical problems. We now routinely implant an ePTFE membrane in all patients undergoing a decompression operation of the lumbar spine.
